Prosecution Insights
Last updated: November 08, 2026

Unigen, Inc.

Technology area: Biotechnology & Pharmaceuticals

6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready

Analysis

Unigen, Inc. has 6 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a distinct examiner and a distinct art unit, creating a fully distributed examination pattern across the active workload.

COHEN, MICHAEL P is the busiest examiner, with 1 pending matter. Since the examiner assignments do not overlap, prosecution management should emphasize consistent claim positions and coordinated disclosure across matters rather than a single examiner-specific approach.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
1
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (33%)
3
Medium (50%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (33%)
§103 only2 (33%)
§112 only1 (17%)
Double-patenting + other1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
COHEN, MICHAEL P 1 59.0% +27.3%
SEITZ, ANTHONY JOSEPH 1 68.2% +26.9%
SCHACHERMEYER, SAMANTHA LYNN 1 35.7% +70.8%
RODRIGUEZ, RAYNA B 1 33.5% +19.2%
PARK, HAEJIN S 1 55.1% +38.3%
CHEN, CATHERYNE 1 37.4% +18.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18974365 Natural Preservatives and Antimicrobial Agents, Including Compositions Thereof COHEN, MICHAEL P —
18133294 DIARYLALKANE COMPOUNDS AND COMPOSITIONS FOR USE WITH SKIN AGING AND METHODS OF PRODUCTION THEREOF SEITZ, ANTHONY JOSEPH —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17389001 Standardized Bioflavonoid Composition for Regulation of Homeostasis of Host Defense Mechanism RODRIGUEZ, RAYNA B 60d overdue
17164231 COMPOSITIONS OF BAKUCHIOL AND METHODS OF MAKING THE SAME CHEN, CATHERYNE 60d overdue
18113370 COMPOSITIONS AND METHODS FOR JOINT HEALTH SCHACHERMEYER, SAMANTHA LYNN 18d overdue
18974365 Natural Preservatives and Antimicrobial Agents, Including Compositions Thereof COHEN, MICHAEL P —
18133294 DIARYLALKANE COMPOUNDS AND COMPOSITIONS FOR USE WITH SKIN AGING AND METHODS OF PRODUCTION THEREOF SEITZ, ANTHONY JOSEPH —
17169490 Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis PARK, HAEJIN S —

Top Art Units

Art UnitApps
1612 1
1629 1
1693 1
1628 1
1614 1
1655 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18974365 Natural Preservatives and Antimicrobial Agents, Including Compositions Thereof COHEN, MICHAEL P 1612 §101§103§112DP Non-Final OA — Pending Dec 09, 2024
18133294 DIARYLALKANE COMPOUNDS AND COMPOSITIONS FOR USE WITH SKIN AGING AND METHODS OF PRODUCTION THEREOF SEITZ, ANTHONY JOSEPH 1629 §101§102§103§112DP Final Rejection — Pending Apr 11, 2023
18113370 COMPOSITIONS AND METHODS FOR JOINT HEALTH SCHACHERMEYER, SAMANTHA LYNN 1693 §103 Final Rejection 18d overdue Pending Feb 23, 2023
17389001 Standardized Bioflavonoid Composition for Regulation of Homeostasis of Host Defense Mechanism RODRIGUEZ, RAYNA B 1628 §103§112DP Final Rejection 60d overdue Pending Jul 29, 2021
17169490 Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis PARK, HAEJIN S 1614 §112 Final Rejection — Pending Feb 07, 2021
17164231 COMPOSITIONS OF BAKUCHIOL AND METHODS OF MAKING THE SAME CHEN, CATHERYNE 1655 §103 Final Rejection 60d overdue Pending Feb 01, 2021

Managing Unigen, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Unigen, Inc. have?

Unigen, Inc. has 6 pending office actions as of November 2026, spread across 6 art units and 6 examiners.

Which USPTO examiner handles the most Unigen, Inc. applications?

Michael P Cohen has the most, with 1 of Unigen, Inc.'s pending office actions.

What technology area are Unigen, Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month